Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis

Abstract Background As cell-free nanotherapeutics, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have shown potential therapeutic action against liver diseases. However, their effects on autoimmune hepatitis (AIH) are not yet well understood. Methods and results In this study,...

Full description

Saved in:
Bibliographic Details
Main Authors: Fan Yang, Beibei Ni, Xiaoqi Liang, Yizhan He, Chao Yuan, Jiajie Chu, Yiju Huang, Hongyu Zhong, Li Yang, Jianxi Lu, Yan Xu, Qi Zhang, Wenjie Chen
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-024-04013-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544940487704576
author Fan Yang
Beibei Ni
Xiaoqi Liang
Yizhan He
Chao Yuan
Jiajie Chu
Yiju Huang
Hongyu Zhong
Li Yang
Jianxi Lu
Yan Xu
Qi Zhang
Wenjie Chen
author_facet Fan Yang
Beibei Ni
Xiaoqi Liang
Yizhan He
Chao Yuan
Jiajie Chu
Yiju Huang
Hongyu Zhong
Li Yang
Jianxi Lu
Yan Xu
Qi Zhang
Wenjie Chen
author_sort Fan Yang
collection DOAJ
description Abstract Background As cell-free nanotherapeutics, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have shown potential therapeutic action against liver diseases. However, their effects on autoimmune hepatitis (AIH) are not yet well understood. Methods and results In this study, we utilized a well-established concanavalin A (Con A)-induced fulminant hepatitis mouse model to investigate the effects of MSC-EVs on AIH. We found that MSC-EVs provide significant protection against Con A-induced hepatitis in C57BL/6 male mice, with their effectiveness being critically dependent on the gut microbiota. MSC-EVs modulate the composition of the gut microbiota, particularly by increasing the abundance of norank_f__Muribaculaceae, and impact liver metabolic profiles, leading to significant amelioration of liver injury. The identification of Acetyl-DL-Valine as a protective metabolite underscores the therapeutic potential of targeting gut‒liver axis interactions in liver diseases. Conclusion Overall, our data demonstrate that MSC-EVs exhibit nanotherapeutic potential in Con A-induced hepatitis and provide new insights into the treatment of autoimmune hepatitis. Graphical Abstract
format Article
id doaj-art-dd19e8820ef544129ca01c10ecdb24a6
institution Kabale University
issn 1757-6512
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj-art-dd19e8820ef544129ca01c10ecdb24a62025-01-12T12:10:18ZengBMCStem Cell Research & Therapy1757-65122025-01-0116111610.1186/s13287-024-04013-7Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axisFan Yang0Beibei Ni1Xiaoqi Liang2Yizhan He3Chao Yuan4Jiajie Chu5Yiju Huang6Hongyu Zhong7Li Yang8Jianxi Lu9Yan Xu10Qi Zhang11Wenjie Chen12Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityCell–Gene Therapy Translational Medicine Research Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityCell–Gene Therapy Translational Medicine Research Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University Zhaoqing hospitalGeneral practice, Guangdong provincial people’s hospitalCell–Gene Therapy Translational Medicine Research Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityCell–Gene Therapy Translational Medicine Research Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityCell–Gene Therapy Translational Medicine Research Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityBiotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityBiotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityBiotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityBiotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityBiotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen UniversityAbstract Background As cell-free nanotherapeutics, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have shown potential therapeutic action against liver diseases. However, their effects on autoimmune hepatitis (AIH) are not yet well understood. Methods and results In this study, we utilized a well-established concanavalin A (Con A)-induced fulminant hepatitis mouse model to investigate the effects of MSC-EVs on AIH. We found that MSC-EVs provide significant protection against Con A-induced hepatitis in C57BL/6 male mice, with their effectiveness being critically dependent on the gut microbiota. MSC-EVs modulate the composition of the gut microbiota, particularly by increasing the abundance of norank_f__Muribaculaceae, and impact liver metabolic profiles, leading to significant amelioration of liver injury. The identification of Acetyl-DL-Valine as a protective metabolite underscores the therapeutic potential of targeting gut‒liver axis interactions in liver diseases. Conclusion Overall, our data demonstrate that MSC-EVs exhibit nanotherapeutic potential in Con A-induced hepatitis and provide new insights into the treatment of autoimmune hepatitis. Graphical Abstracthttps://doi.org/10.1186/s13287-024-04013-7Extracellular vesiclesMesenchymal stromal cellsCon A-induced hepatitisGut microbiota
spellingShingle Fan Yang
Beibei Ni
Xiaoqi Liang
Yizhan He
Chao Yuan
Jiajie Chu
Yiju Huang
Hongyu Zhong
Li Yang
Jianxi Lu
Yan Xu
Qi Zhang
Wenjie Chen
Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis
Stem Cell Research & Therapy
Extracellular vesicles
Mesenchymal stromal cells
Con A-induced hepatitis
Gut microbiota
title Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis
title_full Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis
title_fullStr Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis
title_full_unstemmed Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis
title_short Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis
title_sort mesenchymal stromal cell derived extracellular vesicles as nanotherapeutics for concanavalin a induced hepatitis modulating the gut liver axis
topic Extracellular vesicles
Mesenchymal stromal cells
Con A-induced hepatitis
Gut microbiota
url https://doi.org/10.1186/s13287-024-04013-7
work_keys_str_mv AT fanyang mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT beibeini mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT xiaoqiliang mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT yizhanhe mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT chaoyuan mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT jiajiechu mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT yijuhuang mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT hongyuzhong mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT liyang mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT jianxilu mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT yanxu mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT qizhang mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis
AT wenjiechen mesenchymalstromalcellderivedextracellularvesiclesasnanotherapeuticsforconcanavalinainducedhepatitismodulatingthegutliveraxis